Effects of CYP3A4*22 and POR*28 variations on the pharmacokinetics of tacrolimus in renal transplant recipients: a meta-analysis of 18 observational studies

被引:0
|
作者
Ze Li
Xiaozhen Wang
Dandan Li
Sheng Cheng
Zhe Li
Heng Guo
Yiwen Dong
Yingming Zheng
Xingang Li
机构
[1] Beijing Friendship Hospital,Department of Pharmacy
[2] Capital Medical University,Central Laboratory
[3] Xuanwu Hospital,undefined
[4] Capital Medical University,undefined
来源
关键词
Meta-analysis; Genetic polymorphisms; Tacrolimus; Pharmacokinetics; Renal transplant recipients;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Effect of CYP3A4*22, POR*28, and PPARA rs4253728 on Sirolimus In Vitro Metabolism and Trough Concentrations in Kidney Transplant Recipients
    Woillard, Jean-Baptiste
    Kamar, Nassim
    Coste, Sandra
    Rostaing, Lionel
    Marquet, Pierre
    Picard, Nicolas
    CLINICAL CHEMISTRY, 2013, 59 (12) : 1761 - 1769
  • [32] Impact of the CYP3A4*1G Polymorphism and Its Combination with CYP3A5 Genotypes on Tacrolimus Pharmacokinetics in Japanese Renal Transplant Recipients
    Satoh, S.
    Miura, M.
    Kagaya, H.
    Saito, M.
    Numakura, K.
    Tsuchiya, N.
    Habuchi, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 83 - 83
  • [33] Pharmacogenetics of CYP3A4, CYP3A5, CYP2C8 and CYP2C19 and Their Influence on Tacrolimus Pharmacokinetics in Renal Transplant Recipients
    Wang, Zijie
    Han, Zhijian
    Tao, Jun
    Chen, Hao
    Li, Sun
    Tan, Ruoyun
    Gu, Min
    TRANSPLANTATION, 2018, 102 : S281 - S281
  • [34] CYP3A4/5 polymorphisms affect the blood level of cyclosporine and tacrolimus in Chinese renal transplant recipients
    Li, Dan-ying
    Teng, Rui-chen
    Zhu, Huai-jun
    Fang, Yun
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2013, 51 (06) : 466 - 474
  • [35] THE EFFECT OF CYP3A4 AND CYP3A5 POLYMORPHISMS ON THE TACROLIMUS PLASMA CONCENTRATION IN CHINESE POST RENAL TRANSPLANT RECIPIENTS
    Wen, Gaiyan
    Yuan, Hong
    Xi, Lanyan
    Huang, Zhijun
    Li, Ying
    Lu, Yao
    JOURNAL OF HYPERTENSION, 2016, 34 : E300 - E300
  • [36] Tacrolimus population pharmacokinetic models according to CYP3A5/CYP3A4/POR genotypes in Chinese Han renal transplant patients
    Zhu, Wan
    Xue, Ling
    Peng, Hongwei
    Duan, Zhouping
    Zheng, Xuelian
    Cao, Duanwen
    Wen, Jinhua
    Wei, Xiaohua
    PHARMACOGENOMICS, 2018, 19 (13) : 1013 - 1025
  • [37] A New Functional CYP3A4 Intron 6 Polymorphism Significantly Affects Tacrolimus Pharmacokinetics in Kidney Transplant Recipients
    Elens, Laure
    Bouamar, Rachida
    Hesselink, Dennis A.
    Haufroid, Vincent
    van der Heiden, Ilse P.
    van Gelder, Teun
    van Schaik, Ron H. N.
    CLINICAL CHEMISTRY, 2011, 57 (11) : 1574 - 1583
  • [38] Impact of Combined Cyp3a5, Cyp3a4 and Por*28 Genotypes on Tacrolimus Dose Requirements in Early Phase Kidney Transplant Patients
    Elsharkawy, M.
    Ismail, D. A.
    Lotfy, N. M.
    Mahmoud, M. A.
    Ebid, A. I.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S428 - S429
  • [39] Effect of CYP3A4*22, CYP3A5*3 and POR*28 genetic polymorphisms on calcineurin inhibitors dose requirements in early phase renal transplant patients
    Ebid, Abdel-Hameed I. M.
    Ismail, Dina A.
    Lotfy, Neama M.
    Mahmoud, Mohamed A.
    El-Sharkawy, Magdy
    PHARMACOGENETICS AND GENOMICS, 2024, 34 (02): : 43 - 52
  • [40] Effects of CYP3A5 polymorphisms on tacrolimus pharmacokinetics in pediatric kidney transplantation: a systematic review and meta-analysis of observational studies
    Yi-Ping Zong
    Zi-Jie Wang
    Wan-Li Zhou
    Wei-Min Zhou
    Tie-Liang Ma
    Zheng-Kai Huang
    Chun-Chun Zhao
    Zhen Xu
    Ruo-Yun Tan
    Min Gu
    World Journal of Pediatrics, 2017, 13 : 421 - 426